Official: FDA uses risk-based approach for device-trial inspections

12/7/2008 | FDAnews

The FDA is using a quantitative risk-based strategy as an early intervention in evaluating clinical trials of medical devices, said an official with the Center for Devices and Radiological Health. This method involves small and medium-sized institutional review boards as well as those "that have never been inspected or not in a very long time," the official said.

View Full Article in:

FDAnews

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Sr. Principal Electrical Engineer - 14000008LR
Abbott
San Jose, CA
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA